These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38450511)

  • 21. Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor.
    Inaba T; Matsuda M; Shimamura M; Takei N; Terasaka N; Ando Y; Yasumo H; Koishi R; Makishima M; Shimomura I
    J Biol Chem; 2003 Jun; 278(24):21344-51. PubMed ID: 12672813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Lipid-Modulating Effect of Tangeretin on the Inhibition of Angiopoietin-like 3 (ANGPTL3) Gene Expression through Regulation of LXRα Activation in Hepatic Cells.
    Chen PY; Chao TY; Hsu HJ; Wang CY; Lin CY; Gao WY; Wu MJ; Yen JH
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue-specific epigenetics of atherosclerosis-related ANGPT and ANGPTL genes.
    Ehrlich KC; Lacey M; Ehrlich M
    Epigenomics; 2019 Feb; 11(2):169-186. PubMed ID: 30688091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-GWAS methodologies for localisation of functional non-coding variants: ANGPTL3.
    Oldoni F; Palmen J; Giambartolomei C; Howard P; Drenos F; Plagnol V; Humphries SE; Talmud PJ; Smith AJ
    Atherosclerosis; 2016 Mar; 246():193-201. PubMed ID: 26800306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Broadening the Scope of Dyslipidemia Therapy by Targeting APOC3 (Apolipoprotein C3) and ANGPTL3 (Angiopoietin-Like Protein 3).
    Ginsberg HN; Goldberg IJ
    Arterioscler Thromb Vasc Biol; 2023 Mar; 43(3):388-398. PubMed ID: 36579649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ANGPTL3 inhibits renal cell carcinoma metastasis by inhibiting VASP phosphorylation.
    Zhao T; Liang X; Chen J; Bao Y; Wang A; Gan X; Lu X; Wang L
    Biochem Biophys Res Commun; 2019 Aug; 516(3):880-887. PubMed ID: 31270029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides.
    Graham MJ; Lee RG; Brandt TA; Tai LJ; Fu W; Peralta R; Yu R; Hurh E; Paz E; McEvoy BW; Baker BF; Pham NC; Digenio A; Hughes SG; Geary RS; Witztum JL; Crooke RM; Tsimikas S
    N Engl J Med; 2017 Jul; 377(3):222-232. PubMed ID: 28538111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-ANGPTL3-FLD monoclonal antibody treatment ameliorates podocyte lesions through attenuating mitochondrial damage.
    Lv Q; Han X; Ni J; Ma Q; Dai R; Liu J; Liu J; Zhai Y; Shen Q; Sun L; Liu H; Rao J; Xu H
    Cell Death Dis; 2022 Oct; 13(10):867. PubMed ID: 36229446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statin therapy reduces plasma angiopoietin-like 3 (ANGPTL3) concentrations in hypercholesterolemic patients via reduced liver X receptor (LXR) activation.
    Reeskamp LF; Tromp TR; Huijgen R; Stroes ESG; Hovingh GK; Grefhorst A
    Atherosclerosis; 2020 Dec; 315():68-75. PubMed ID: 33242792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-operative levels of angiopoietin protein-like 3 (ANGPTL3) in women diagnosed with high-grade serous carcinoma of the ovary.
    Wong Chong E; Joncas FH; Douville P; Bachvarov D; Diorio C; Calon F; Bergeron AC; Blais J; Leung SOA; Seidah NG; Gangloff A
    Lipids Health Dis; 2024 Feb; 23(1):59. PubMed ID: 38414008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic ANGPTL3 regulates adipose tissue energy homeostasis.
    Wang Y; McNutt MC; Banfi S; Levin MG; Holland WL; Gusarova V; Gromada J; Cohen JC; Hobbs HH
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):11630-5. PubMed ID: 26305978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ANGPTL3 Deficiency and Protection Against Coronary Artery Disease.
    Stitziel NO; Khera AV; Wang X; Bierhals AJ; Vourakis AC; Sperry AE; Natarajan P; Klarin D; Emdin CA; Zekavat SM; Nomura A; Erdmann J; Schunkert H; Samani NJ; Kraus WE; Shah SH; Yu B; Boerwinkle E; Rader DJ; Gupta N; Frossard PM; Rasheed A; Danesh J; Lander ES; Gabriel S; Saleheen D; Musunuru K; Kathiresan S;
    J Am Coll Cardiol; 2017 Apr; 69(16):2054-2063. PubMed ID: 28385496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptomic therapy for dyslipidemias utilizing nucleic acids targeted at ANGPTL3.
    Watts GF; Raal FJ; Chan DC
    Future Cardiol; 2022 Feb; 18(2):143-153. PubMed ID: 34651521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure and Function of Angiopoietin-like Protein 3 (ANGPTL3) in Atherosclerosis.
    Lu X
    Curr Med Chem; 2020; 27(31):5159-5174. PubMed ID: 31223079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The lipoprotein lipase inhibitor ANGPTL3 is negatively regulated by thyroid hormone.
    Fugier C; Tousaint JJ; Prieur X; Plateroti M; Samarut J; Delerive P
    J Biol Chem; 2006 Apr; 281(17):11553-9. PubMed ID: 16505486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiopoietin-like 3 regulates hepatocyte proliferation and lipid metabolism in zebrafish.
    Lee SH; So JH; Kim HT; Choi JH; Lee MS; Choi SY; Kim CH; Kim MJ
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1237-42. PubMed ID: 24685482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic fat changes with antisense oligonucleotide therapy targeting ANGPTL3.
    Zimerman A; Wiviott SD; Park JG; Murphy SA; Ran X; Bramson CR; Curto M; Ramos V; Jevne A; Kuder JF; Verma S; Wojakowski W; Terra SG; Sabatine MS; Bergmark BA; Marston NA
    J Clin Lipidol; 2024; 18(2):e261-e268. PubMed ID: 38158248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of oral lipid and glucose tolerance tests on the postprandial concentrations of angiopoietin-like proteins (Angptl) 3 and 4.
    Schmid A; Belikan H; Höpfinger A; Schäffler A; Karrasch T
    Eur J Nutr; 2022 Jun; 61(4):1919-1929. PubMed ID: 34951653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease.
    Dewey FE; Gusarova V; Dunbar RL; O'Dushlaine C; Schurmann C; Gottesman O; McCarthy S; Van Hout CV; Bruse S; Dansky HM; Leader JB; Murray MF; Ritchie MD; Kirchner HL; Habegger L; Lopez A; Penn J; Zhao A; Shao W; Stahl N; Murphy AJ; Hamon S; Bouzelmat A; Zhang R; Shumel B; Pordy R; Gipe D; Herman GA; Sheu WHH; Lee IT; Liang KW; Guo X; Rotter JI; Chen YI; Kraus WE; Shah SH; Damrauer S; Small A; Rader DJ; Wulff AB; Nordestgaard BG; Tybjærg-Hansen A; van den Hoek AM; Princen HMG; Ledbetter DH; Carey DJ; Overton JD; Reid JG; Sasiela WJ; Banerjee P; Shuldiner AR; Borecki IB; Teslovich TM; Yancopoulos GD; Mellis SJ; Gromada J; Baras A
    N Engl J Med; 2017 Jul; 377(3):211-221. PubMed ID: 28538136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of
    Qiu M; Glass Z; Chen J; Haas M; Jin X; Zhao X; Rui X; Ye Z; Li Y; Zhang F; Xu Q
    Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.